Peter Anastasiou
Presidente presso ALDER BIOPHARMACEUTICALS, INC.
Posizioni attive di Peter Anastasiou
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Presidente | - | - |
HARMONY BIOSCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 05/11/2023 | - |
Independent Dir/Board Member | 05/11/2023 | - | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Direttore/Membro del Consiglio | 01/07/2017 | - |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Direttore/Membro del Consiglio | 01/01/2022 | - |
Amministratore Delegato | 01/01/2022 | - |
Storia della carriera di Peter Anastasiou
Precedenti posizioni note di Peter Anastasiou
Società | Posizione | Inizio | Fine |
---|---|---|---|
H. LUNDBECK A/S | Corporate Officer/Principal | 01/01/2009 | 31/12/2021 |
BRISTOL-MYERS SQUIBB COMPANY | Vendite & Marketing | - | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
NEURONETICS, INC. | Vendite & Marketing | 10/04/2006 | - |
Formazione di Peter Anastasiou
Albion College | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Danimarca | 2 |
Posizioni
Director/Board Member | 3 |
Sales & Marketing | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
NEURONETICS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
H. LUNDBECK A/S | Health Technology |
HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
- Borsa valori
- Insiders
- Peter Anastasiou
- Esperienza